GlassScriptPhysician profile
Erik Borncamp
NPI 1689647661
$363,581.38
in general payments reported to CMS, 2019-2025
29 companies · $17K in 2025
The $17K reported for 2025 was more than what 97% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69K · 2020: $82K · 2021: $54K · 2022: $67K · 2023: $48K · 2024: $27K · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $85K · Food and Beverage: $5,270 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,500 · Travel and Lodging: $734.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $84,756.33 |
| Food and Beverage | $5,269.72 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,500.00 |
| Travel and Lodging | $734.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $361,506.03 | 2019-2025 | Da Vinci Surgical System |
| Smith+Nephew, INC. | $665.31 | 2019-2025 | Renasys Go V2 Home, Stravix |
| Davol INC. | $224.61 | 2019-2024 | Phasix Mesh |
| Kerecis Limited | $151.99 | 2022-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Baxter Healthcare | $139.51 | 2024 | Perclot |
| Nestle Healthcare Nutrition INC. | $111.52 | 2023 | |
| Solventum Corporation | $110.51 | 2024 | Prevena |
| Integra Lifesciences Corporation | $72.98 | 2019-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Braintree Laboratories, INC. | $61.94 | 2021-2022 | |
| Organogenesis INC. | $51.85 | 2022 | |
| Merck Sharp & Dohme LLC | $49.91 | 2024-2025 | Bridion, Lynparza, Keytruda |
| Vertex Pharmaceuticals Incorporated | $48.48 | 2025 | |
| Polynovo North America LLC | $40.73 | 2022-2024 | Novosorb Btm |
| W. L. Gore & Associates, INC. | $36.62 | 2019 | |
| Ambu INC. | $32.74 | 2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $26.84 | 2023 | V.A.C. Veraflo Cleanse Choice |
| Takeda Pharmaceuticals U.S.A., INC. | $26.74 | 2023 | Gattex |
| Acell, INC. | $26.17 | 2020 | |
| Osiris Therapeutics INC. | $25.75 | 2019 | |
| Innocoll Pharmaceuticals Limited | $24.27 | 2022 | |
| Dilon Technologies, INC. | $24.24 | 2022 | |
| Innovation Technologies INC | $23.86 | 2020 | |
| Acera Surgical, INC. | $23.31 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $21.23 | 2022 | |
| Coopersurgical, INC. | $16.74 | 2025 | Onetrac Lx |
| Surgenex LLC | $13.56 | 2025 | Renograft, Surmatrix, Ardeograft |
| Tei Biosciences INC | $12.72 | 2019 | |
| Monaghan Medical Corporation | $11.22 | 2023 | Aeroeclipse |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erik Borncamp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.